Background: Atopic dermatitis (AD) is caused by a complex interplay between immune and barrier abnormalities. Murine models of AD are essential for preclinical assessments of new treatments. Although many models have been used to simulate AD, their transcriptomic profiles are not fully understood, and a comparison of these models with the human AD transcriptomic fingerprint is lacking. Objective: We sought to evaluate the transcriptomic profiles of 6 common murine models and determine how they relate to human AD skin.
Atopic dermatitis (AD) is the most common inflammatory skin disease 1 and is caused by an interplay between immune and barrier abnormalities. 2, 3 Unlike psoriasis, another common inflammatory skin disease that is largely T H 17/IL-23 polarized, 2 AD is characterized by activation of multiple cytokine pathways. 4, 5 In addition to immune activation, reduced expression of barrier components (terminal differentiation proteins, tight junctions, and lipids) is also characteristic of AD. [6] [7] [8] [9] Transcriptomic profiling of AD tissues at baseline and after treatment with broad and specific agents has recently increased our understanding of the disease. [10] [11] [12] Although these studies highlight a critical role for the T H 2 axis in patients with AD, 10 ,13,14 they also suggest increased T H 17/IL-23 and T H 22 activation in patients with AD, particularly in some subtypes (ie, Asian and intrinsic AD). 4, 5, 15 Although human testing is needed to elucidate the pathogenic contributions of various cytokines in patients with AD, murine AD models are essential for assessing new drugs at the preclinical level. 16, 17 An ideal murine model should replicate both the epidermal barrier disruption and cutaneous inflammation of the human disease. Although many models have been used to simulate human AD, their transcriptomic profiles and relevance to the AD skin profile are not fully understood because a direct comparison between frequently used models and human AD is lacking. A number of spontaneous genetically engineered and inducible ''AD-like'' models have been described. These include NC/Nga, 16 flaky tail (Tmem79 ma/ma Flg ft/ft ), 18, 19 Flg-mutated (Flg ft/ft ), 20 oxazolone (OXA)-challenged, 21, 22 and ovalbumin (OVA)-challenged mice. [23] [24] [25] [26] Furthermore, the IL-23-injected mouse model, which has been traditionally considered to resemble psoriasis 27, 28 and exhibits the largest (25%) transcriptomic homology with human psoriasis fingerprinting among existing ''psoriasis-like'' models, 29 has also been found to display T H 2 activation and simulate AD-like skin inflammation. 30 Although all murine AD-like models (with the exception of Flg-mutated mice) 16, [18] [19] [20] 22, 24, 27 are visibly inflamed, it is difficult to macroscopically differentiate AD-like dermatitis in mice from lesions mimicking contact dermatitis (CD) or psoriasis. For example, because flaky tail mice exhibit T H 17-dominated skin inflammation, 31, 32 this murine model might more closely simulate a psoriasis-like phenotype rather than AD-like fingerprinting.
To evaluate the transcriptomic profiles of common AD models and determine how closely they resemble the intricate cytokine and epidermal abnormalities in AD skin, we profiled 5 common AD-like murine models, as well as the IL-23-injected model, which was previously considered to best mimic psoriasis. To be able to contrast all polar cytokine responses in human subjects, murine profiles were compared with transcriptomic profiles of AD and 2 other common inflammatory skin diseases, psoriasis and CD, that share clinical and tissue characteristics with AD. 9, 33, 34 We found that no single model fully captures all aspects of AD, but surprisingly, IL-23-injected mice show the most similar transcriptomic profile to human AD.
METHODS

Murine models
Transcriptomic profiling was performed with microarrays and quantitative RT-PCR (qRT-PCR) on biopsy specimens from 6 models, including NC/Nga, flaky tail, Flg-mutated, OVA-challenged, OXA-challenged, and IL-23-injected mice. Controls for murine models generally had similar genetic background, comprising the C57BL/6 (flaky tail, Flg-mutated, OVA, and IL-23), NC/Nga without mite infestation (NC/Nga), and BALB/c (OXA) laboratory strains. The samples of flaky tail, Flg-mutated, OVA-challenged, and NC/Nga mice were harvested at Kyoto University, Kyoto, Japan (Table I) . Specimens from OXA-challenged mice were collected at Leo Pharma A/S (Ballerup, Denmark; Table I ). The IL-23-injected mice gene array data were acquired from a previously published cohort (GSE50400), 29 and available RNA samples from these mice were used for qRT-PCR. See the Methods section in this article's Online Repository at www.jacionline.org for more details. The Institutional Animal Care and Use Committee of Kyoto University and Leo Pharma A/S approved all experiments.
Representative images of each model are shown in Fig 1, A. Ear tissues from flaky tail, Flg-mutated, NC/Nga, and OXA-challenged mice were used, whereas dorsal skin was harvested from OVA-challenged and IL-23-injected mice. Flaky tail, 19 NC/Nga, 37 OVA-challenged, 24 and OXA-challenged 22 models exhibit increased serum IgE levels. Flg-mutated mice show normal IgE levels, 38 and IgE data are unavailable for IL-23-injected mice (Table I) . 29 
Human cohorts
AD microarray data were obtained from our meta-analysis-derived atopic dermatitis (MADAD) transcriptome, 9 which was comprised of 4 AD lesional versus nonlesional data sets with a total of 97 samples (41 paired lesional/nonlesional samples).
This study also includes a previously published cohort of 25 patients with AD (9 female and 16 male patients; age, 23-73 years [median, 45 years]) with SCORAD scores from 33 to 77 (mean, 56.7; SD, 12.2) and serum eosinophil counts of 0.6% to 11.8% (median, 4.3%); among patients with AD, 14 (56%) of 25 had extrinsic AD (serum IgE level, 254-3000 kU/L; median, 1292.8 kU/L). 5, 11 Ten previously published patients with moderate-to-severe psoriasis were included for comparisons (Psoriasis Area Severity Index score, 8.4-59.5; mean, 20.3; SD, 14.5). 5, 39 Thirteen previously published patients with allergic CD (n 5 10 with nickel allergy and n 5 3 with fragrance allergy) were included. 33 Biopsy specimens from positive patch tests to these allergens were taken at 72 hours from patch test placement. All these subjects were European Americans. Patients' characteristics are summarized in Table E1 in this article's Online Repository at www.jacionline.org, and the entire list is available in Table E2 in this article's Online Repository at www.jacionline.org.
qRT-PCR and gene arrays
RNA was extracted with EZ-PCR Core Reagents (Life Technologies, Grand Island, NY). RNA was reverse transcribed to cDNA by using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, Calif). TaqMan Low Density Array (TLDA) cards (384-well plates preloaded with TaqMan assays) were used for qRT-PCR. For IFN-g, IL-13, and IL-17A, which are frequently undetectable with TLDA, single TaqMan quantitative PCR was performed. All primers are listed in Table E3 in this article's Online Repository at www.jacionline.org. For IL-23-injected mice, PCR analyses were performed by using stored samples from a previous report. 29 Expression values (threshold cycle [Ct] ) were normalized to Rplp0.
Affymetrix Mouse Gene 2.1 ST Arrays (Affymetrix, Santa Clara, Calif) were used for flaky tail, Flg-mutated, OVA-challenged, and NC/Nga mice. Affymetrix Mouse Gene 1.0 ST Arrays were used for OXA-challenged mice, whereas the previously published IL-23-injected murine transcriptomic data were analyzed with the GeneChip Mouse Genome 430 2.0 Array (Affymetrix).
The MADAD transcriptome combined all effect sizes for each probe set and identified a set of 595 differentially expressed genes (DEGs; 387 upregulated and 208 downregulated) by using a classical fold change (FCH) of 2 or greater and a false discovery rate (FDR) of 0.05 or less criteria. 9 For qRT-PCR comparison, we used previously published data obtained from the abovementioned human cohorts. Because nonlesional AD skin is abnormal, 40 we also included a comparison of lesional AD to normal skin.
Bioinformatics and statistical analyses
Murine microarray data were preprocessed in R software by using the justRMA function of the affy package and normalized by using the normalize.quantiles.robust or normalize.quantiles.use.target (IL-23 and OXA models) function of the preprocessCore package. 41, 42 Changes in expression profiles of each murine model and its controls were performed by using the linear model framework of limma package. 43 P values from moderated t tests were adjusted for multiple testing by using the Benjamini-Hochberg procedure.
Cross-species annotation from murine to human ensemble IDs was performed with the getLDS function biomart package. [44] [45] [46] [47] Linear models were applied to analyze TLDA and qRT-PCR expression data based on Rplp0 normalized and negative transformed Ct (2dCt) values. Before applying these models to TLDA and qRT-PCR expression data but after normalization, we replaced nondetected 2dCt values with 20% of the minimum dCt for each gene across all samples, while keeping it in the possible range of 240 to 40.
RESULTS
Transcriptomic profiling of AD-like murine models
Although transcriptomic fingerprinting has been thoroughly performed in AD skin, 4, 5, 40, [46] [47] [48] [49] a similar analysis is lacking for AD-like murine models. To establish the individual transcriptomic profiles of prominent AD-like models and their similarity to human disease, we profiled skin from 5 common AD-like models, 19, 20, 22, 24, 37 as well as from the IL-23-injected model, which is considered to best represent the IL-17/IL-23-centered inflammation in patients with psoriasis, 29 by using gene arrays (Table I) . Criteria of an FCH of 2 or greater and an FDR of 0.05 or less were used to define DEGs between diseased murine skin and respective control skin. Lists of DEGs for each model are listed in Table E4 in this article's Online Repository at www.jacionline.org.
AVenn diagram based on unique Human Genome Organisation Gene Nomenclature Committee symbol orthologs and proportional to DEGs illustrates the overlap between murine models (Fig 1, B) . Flaky tail and Flg-mutated models are excluded from the diagram because they display the lowest numbers of DEGs (n 5 226 and n 5 47, respectively), despite being among the largest sample sizes (n 5 5, Table I ). Overall, IL-23-injected mice show the highest number of DEGs (n 5 2753), followed by OXA-challenged (n 5 1004), NC/Nga (n 5 742), and OVA-challenged (n 5 373) mice. Only 67 DEGs are shared among NC/Nga, OVA-challenged, OXA-challenged, and IL-23-injected mice, as represented in the center of the Venn diagram (Fig 1, B) .
Murine models show differential profiles compared with human AD
Each murine transcriptomic profile was compared with the MADAD transcriptome, 9 a robust AD transcriptome across 4 independent cohorts, to compare how well the AD-like and IL-23-injected models represent human AD. The murine transcriptomes represent only 37%, 18%, 17%, and 11% of the human AD profile (MADAD) for IL-23-injected, NC/Nga, OXA-challenged, and OVA-challenged mice, respectively (Fig 1, C) . Table E5 in this article's Online Repository at www.jacionline.org for each model.
Because the choice of cutoffs and hybridization kits can influence intersections between DEGs of various transcriptomes, 50 the MADAD transcriptome and transcriptomes of 6 murine models were also compared by using ranked gene lists instead of cutoffs, as previously described. 28, 29 The 5000 highest upregulated and downregulated genes in each mouse transcriptome were identified and ranked according to FCHs, with lowest ranks assigned to the genes with highest regulations. We then analyzed the overlap of the MADAD transcriptome with ranked genes in each murine model. In Fig 1, D, 35,36 the red and blue lines correspond to the overlap between upregulated and downregulated genes, respectively, of murine models and the MADAD model at any given rank N, where N 5 1, ., 5000. 9 IL-23-injected mice appear separated because these data are from our previous study (GSE50400). 29 D, Overlap between the top upregulated (red) and downregulated (dark blue) genes in each model and the MADAD transcriptome was estimated for rank N 5 1 . 5000. 35 The light blue line outlines the overlap expected by chance, such that any line above it indicates significant overlap. 36 HGNC, Human Genome Organization Gene Nomenclature Committee.
The light blue line outlines the level of overlap expected by chance (the 95% confidence region of hypergeometric distribution under the null hypothesis), such that any line above it indicates a significant level of overlap, and distances farther from it show a higher overlap. 36 For any given rank, IL-23-injected mice represent the highest and most significant overlap with the MADAD transcriptome and in decreasing order for OXA-challenged and NC/Nga mice. The OVA-challenged model has significant overlap with genes upregulated in human AD but does not capture the downregulated signature of human AD. The transcriptomes of flaky tail and Flg-mutated mice have poor overlap with human AD, which is consistent with the standard cutoff-based approaches (Fig 1, B and C) .
An enrichment analysis was also conducted by using Kyoto Encyclopedia of Genes and Genomes pathways to associate different mice profiles with relevant biological functions in human AD. 51, 52 Selected pathways significantly enriched in human AD and in murine models are shown in Fig 2, A, and Table E6 in this article's Online Repository at www.jacionline.org, with the black vertical line representing an FDR of 0.05. The genes represented in each pathway are listed in Table E7 in this article's Online Repository at www.jacionline.org. The most significantly enriched pathways in the MADAD transcriptome include peroxisome proliferator-activated receptor signaling, cytokine-cytokine receptor interaction, Janus kinase-signal transducer and activator of transcription signaling, T-cell receptor signaling, chemokine signaling, cell adhesion molecules, and adipocyte signaling pathways. IL-23-injected mice best simulate the inflammation and lipid pathways in human AD, with enrichments in some pathways also seen with NC/Nga and OXA-challenged mice. OVA-challenged mice only share the cytokine-cytokine receptor interaction, peroxisome proliferator-activated receptor signaling, and biosynthesis of unsaturated fatty acids pathways with the MADAD transcriptome. A single lipid pathway (biosynthesis of unsaturated fatty acids) is shared between Flg-mutated and flaky tail mice and the MADAD transcriptome, although this pathway is not significant for the MADAD transcriptome. Retinol metabolism, hedgehog signaling, and melanogenesis pathways are enriched in flaky tail mice but are not enriched in the MADAD transcriptome. Fig 2, B,  9 illustrates the top 30 upregulated and downregulated MADAD DEGs and their representation in each model (see Table E5 ). Again, IL-23-injected mice best represent not only the upregulated (eg, CCL18, S100A8, and keratin 16 [KRT16]) but also the downregulated DEGs (eg, claudin 8 [CLDN8]) in the MADAD transcriptome, whereas NC/Nga, OVA-challenged, and OXA-challenged mice mostly capture the upregulated but not the 9 Corresponding log 2 (FCH) values are shown. *P < .05, **P < .01, and ***P < .001. Coloring (blue, downregulated; red, upregulated) appears for an absolute log 2 (FCH) value of 1 or greater, with adjusted P values of less than .05. PPAR, Peroxisome proliferator-activated receptor. Transcriptomic homology between mice and inflammatory skin diseases Because the signatures of the 6 murine models showed limited resemblance to human AD, we expanded our comparison to also include transcriptomic profiles of 2 other well-characterized polar inflammatory skin diseases: psoriasis and CD. 5, 11, 33, 39 We then performed unsupervised clustering, with percentages reflecting robustness of each branch in the dendrogram (Fig 3, A) . 55 The B, Principal component analysis using log 2 (FCH) for the 8400 genes. PSO, Psoriasis.
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 2 resultant dendrogram establishes a tight cluster of inflammatory skin diseases, with clear separation from murine models. Flg-mutated and flaky tail mice cluster together and farther apart from other models. To elucidate the relative distances between individual models and human disease and to identify which murine model is closest to the human diseases, we performed a principal component analysis (Fig 3, B) . The principal component analysis plot shows that murine models are separated from inflammatory skin diseases. IL-23-injected mice are closest to the AD profile (MADAD) on the PC1 axis, followed by CD (to fragrance) and surprisingly only then by psoriasis (Fig 3, B) . Indeed, a principal variation component analysis also indicates that the organism explains 41.5% of the variations, with disease or mouse models accounting for only 12% (data not shown).
qRT-PCR highlights significant differences in polar immune activation among murine models qRT-PCR was performed on a wide array of hallmark human AD inflammatory and barrier genes that are often less than detection levels in arrays and share murine orthologs to validate and extend the microarray findings to polar cytokines. mRNA expressions were also compared with those obtained in our AD and psoriasis cohorts and, for selected available genes, also CD (to nickel and fragrance) populations (Fig 4) . 33 Overall, similar patterns are seen in qRT-PCR and gene arrays. IL-23-injected, NC/Nga, OXA-challenged, and OVA-challenged mice show large increases in innate, T H 2, and T H 1 cytokine pathways (IL-1b, IL-13, and IFN-g), as well as increased KRT16 (marking epidermal hyperplasia), 56 and the OXA-challenged model has the highest activation of the T H 2 cytokine IL-13. Only IL-23-injected and NC/Nga mice reflect all diverse cytokine pathways, including IL-17A activation. The downregulation of terminal differentiation genes (filaggrin [FLG] and loricrin [LOR] ) that characterizes AD is best captured by Flg-mutated and flaky tail models and to some extent by IL-23-injected, OVA, and OXA models but is missing in NC/Nga mice.
DISCUSSION
Over the past decades, many murine AD-like models, 19, 20, 22, 24, 37 including humanized AD, 57 topical vitamin D analogue application, 58, 59 or allergen/staphylococcal enterotoxin B models, [58] [59] [60] have been developed as tools for understanding AD pathogenesis Heat map of qRT-PCR-derived mRNA expression differences. CD data are shown separated because data from only 13 genes were available. 33 Corresponding log 2 (FCH) values are shown. 1P < .1, *P < .05, **P < .01, and ***P < .001. Dendrograms represent unsupervised clustering with Euclidean distance and McQuitty agglomeration. LS, Lesional; N/A, not available; NL, nonlesional; PSO, psoriasis.
and as preclinical models. The most complete view of the human AD profile is based on transcriptomic profiling of skin lesions. 4, 5, 9 Key AD features include prominent activation of inflammatory pathways and large defects in epidermal differentiation, tight junctions, and lipid profiles. 40, [46] [47] [48] 61, 62 Unlike psoriasis, which is largely T H 17/IL-23 polarized, AD shows more diverse cytokine expression, with T H 2 but also T H 22 pathway activation, 2 with possible roles also suggested for the IL-23/T H 17 axis, particularly in specific AD populations, such as Asian patients with AD. 5 Global transcriptomic profiling of individual murine models is essential for understanding their distinct cytokine and barrier alterations and how well they resemble human AD fingerprinting compared with profiles of other common polar inflammatory skin diseases. 28, 29 This study is the first to evaluate the fingerprinting of commonly used AD-like (and a representative psoriasis-like) murine models and their relevance to human AD but also to psoriasis and CD.
A proper model of human AD skin should appropriately represent its 2 main features: relevant cytokine networks and epidermal pathology. However, our data suggest that no single murine model is able to accurately simulate both aspects of AD. Our data separate the models into 2 clusters. One group includes flaky tail and Flg-mutated mice, which are least reminiscent of human AD, particularly of its immune skewing. Flaky tail mice show a T H 17-dominated polarization, and Flg-mutated mice demonstrate no apparent clinical or tissue inflammation, which is quite different from the human AD profile. The other group, including IL-23-injected, NC/Nga, OXA-challenged, and OVA-challenged mice, show a broad range of polar immune activation. With the exception of the IL-23-injected model, which simulates some barrier features of human AD, such as reductions in tight junctions (CLDN8), lipids, and LOR, other models in this group mostly do not reflect the epidermal abnormalities of AD.
Surprisingly, among all evaluated models, IL-23-injected mice show the largest overlap with human AD skin, which is unexpected because this model has been traditionally used for psoriasis. 63 This model demonstrates remarkable activation of innate immunity; the T H 1, T H 2, and T H 17/IL-23 axes; and some epidermal alterations. Still, IL-23-injected mice have increased neutrophil counts and only sparse eosinophils and mast cells, 29, 30 which can be found in human patients with AD. 64, 65 Furthermore, FLG downregulation, which represents a hallmark of AD, is absent in this model. This model thus replicates the T H 2 activation of AD, as well as the T H 17/T H 22 signature of psoriasis and some AD subtypes. Although IgE levels have not been evaluated in our IL-23 model, 29, 30 IgE responses take at least several weeks to develop. 24 Perhaps, unlike other models, which have more chronic T-cell activation and are able to induce IgE responses over time, the IL-23 model is a short-term skin inflammation model (profile is created within 7 days).
Although the NC/Nga model does not reflect the various barrier defects of human AD, including decreases in differentiation, tight junctions, and lipids (ie, FLG, LOR, CLDN8, and ELOVL3), 9, 40, [46] [47] [48] it clearly shows the diverse immune polarizations in human AD, including innate, T H 1, T H 2, and T H 17 pathways. Thus NC/Nga mice might be useful to investigate the complex cytokine interactions but not the barrier aberrations of patients with AD. OVA-challenged mice also replicate activation of inflammatory pathways in patients with AD, although to a lesser extent than IL-23-injected and NC/Nga models.
OXA-challenged mice demonstrate high T H 1 and marginal T H 2 inductions, with only limited barrier defects (LOR). IL-17A induction is absent in these mice, but a few downstream mediators (S100A8 and lipocalin 2 [LCN2]) are upregulated.
Flaky tail mice show selective T H 17 activation, as previously reported. 31, 32 Although the T H 17 axis is a central driver of psoriasis, some role of this pathway in patients with AD, including induction of the T H 2 axis, has recently been suggested. 5, 66, 67 Thus although flaky tail mice replicate some T H 17 activation and reductions in FLG and LOR seen in patients with AD, data obtained from these mice should be applied cautiously to human AD because this model lacks T H 2 activation, which is the hallmark of the AD immune response.
Flg-mutated mice are the only murine model showing significant downregulation of FLG, similar to reductions observed in human AD. [68] [69] [70] However, Flg-mutated mice lack both clinical and transcriptomic skin inflammation 20 and additional barrier abnormalities that are seen in patients with AD, suggesting its limited use as a model to replicate the inflammation and global barrier defects in AD. A summary of clinical and laboratory characteristics of all analyzed models is provided in Table II . 16, 19, 20, 22, 24, 27, 30 Human inflammatory skin diseases share a number of features but maintain distinct differences in tissue structure and immune activation. Although downregulation of differentiation genes clearly differentiates AD from the other 2 inflammatory skin diseases, other immune and epidermal features are shared among the 3 conditions. These characteristics include increased epidermal hyperplasia and activation of T H 1, T H 17, and T H 22 pathways, although, as expected, T H 2 polarization is minimal in patients with psoriasis compared with that seen in patients with AD. 5 Our study has several limitations. First, only mRNA and not protein levels were measured, and assessments were limited to a single time point. Second, we mainly used B6 mice, although BALB/c mice might be more appropriate in certain cases. Third, we did not perform functional in vivo tests (ie, transepidermal water loss, corneal water content, and pruritus measures). 16, 22 The biopsy specimens were taken from different locations and at different ages in mice, possibly affecting gene expression. 71 Finally, comparisons with different AD endotypes were not possible here and should be addressed in future larger cohort studies of various ages and races. Overall, no single murine model fully captures all immune and barrier aspects of human AD skin, and phenotypic differences between AD and murine models are significant, regardless of which model is chosen. Nevertheless, of the models studied, IL-23-injected mice appear to best replicate the human AD profile. IL-23-injected and NC/Nga mice demonstrate a wide array of inflammatory axes, including T H 2 activation, and are best suited to assess this AD-centric axis and how it interacts with other activated cytokines in patients with AD. OXA-challenged and OVA-challenged mice, despite showing remarkable inflammation, are not necessarily AD specific. IL-23-injected, OXA-challenged, and OVA-challenged models have the advantage that inducing agents can be used on different mouse backgrounds, including existing knockouts of specific genes, to dissect cutaneous inflammation. Flaky tail mice do not capture any key features of human AD. Flg-mutated mice are best only to represent the FLG downregulation in patients with AD but not other AD characteristics. Thus the choice of which murine model to use depends on the translational focus of the investigator, but caution should be exercised when translating murine data to human inflammatory skin diseases.
